Portola Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PORTOLA PHARMS INC, and when can generic versions of PORTOLA PHARMS INC drugs launch?
PORTOLA PHARMS INC has one approved drug.
There are five US patents protecting PORTOLA PHARMS INC drugs.
There are sixty-three patent family members on PORTOLA PHARMS INC drugs in twenty-six countries.
Summary for Portola Pharms Inc
| International Patents: | 63 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Portola Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | 7,598,276 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | 8,987,463 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | 8,404,724 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | 8,404,724 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | 8,557,852 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | 9,555,023 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Portola Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 8,691,847 | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | 6,376,515 | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 6,835,739 | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | 9,629,831 | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 8,518,977 | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 9,629,831 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Portola Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 2101760 | ⤷ Subscribe |
| Ecuador | SP099501 | ⤷ Subscribe |
| Japan | 5766204 | ⤷ Subscribe |
| Hong Kong | 1134031 | ⤷ Subscribe |
| South Korea | 101358574 | ⤷ Subscribe |
| European Patent Office | 2513058 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
